Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in US

Reuters2026/07/22 11:04

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

FDA granted De Novo market authorization for Johnson & Johnson’s OTTAVA robotic surgical system in the U.S.
Cleared for multiple upper-abdominal general surgery procedures, including bariatric surgery, gallbladder removal, appendectomy.
Company plans a limited U.S. commercial launch with select customers while pursuing additional indications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 202607220700BIZWIRE_USPR_____20260717_BW254564) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in US

You may also like

Crypto prices